- Trials with a EudraCT protocol (51)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
51 result(s) found for: Postherpetic Neuralgia.
Displaying page 1 of 3.
EudraCT Number: 2007-005781-12 | Sponsor Protocol Number: A6631013 | Start Date*: 2008-03-12 | |||||||||||
Sponsor Name:Pfizer Limited, Ramsgate Road, Sandwich, Kent UK | |||||||||||||
Full Title: A FOUR WEEK, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 2A STUDY OF PH-797804 IN THE TREATMENT OF POST-HERPETIC NEURALGIA | |||||||||||||
Medical condition: Post-herpetic neuralgia (PHN) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) SE (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-002473-31 | Sponsor Protocol Number: SCO/BIA-2093-207 | Start Date*: 2007-10-12 | |||||||||||
Sponsor Name:BIAL - Portela & Ca, S.A. | |||||||||||||
Full Title: EFFICACY AND SAFETY OF ESLICARBAZEPINE ACETATE (BIA 2 093) AS THERAPY FOR PATIENTS WITH POST-HERPETIC NEURALGIA: A DOUBLE-BLIND, DOUBLE-DUMMY, RANDOMISED, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTIC... | |||||||||||||
Medical condition: adult patients with post-herpetic neuralgia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PT (Completed) LT (Completed) AT (Completed) CZ (Completed) FR (Completed) HU (Completed) DE (Completed) SK (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-004639-26 | Sponsor Protocol Number: LX9211.1-202-PHN | Start Date*: 2021-05-19 | |||||||||||
Sponsor Name:Lexicon Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 2, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of LX9211 in the Treatment of Postherpetic Neuralgia (RELIEF-PHN1) | |||||||||||||
Medical condition: Postherpetic Neuralgia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Ongoing) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000399-41 | Sponsor Protocol Number: ESTEVE-SIGM-203 | Start Date*: 2012-07-23 | |||||||||||
Sponsor Name:Laboratorios del Dr. Esteve. S.A. | |||||||||||||
Full Title: An exploratory, randomized, double blind, placebo controlled, parallel groups Phase II clinical trial to evaluate the efficacy and safety of E-52862 (400 mg) by oral route, in patients with posther... | |||||||||||||
Medical condition: Postherpetic Neuralgia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-002563-24 | Sponsor Protocol Number: A0081004 | Start Date*: 2005-02-25 | |||||||||||
Sponsor Name:Pfizer Ltd | |||||||||||||
Full Title: A double blind, randomised, placebo controlled trial of the time to onset of meaningful pain relief in subjects with post herpetic neuralgia (PHN) treated with pregabalin (150-600 mg /day flexible ... | |||||||||||||
Medical condition: post herpetic neuralgia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) IT (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-002521-27 | Sponsor Protocol Number: 8477-CL-0020 | Start Date*: 2014-05-08 | ||||||||||||||||
Sponsor Name:Astellas Pharma Europe B.V. (APEB) | ||||||||||||||||||
Full Title: A Phase 2a Enriched Enrollment Randomized Withdrawal Study to Assess Analgesic Efficacy and Safety of ASP8477 in Subjects with Peripheral Neuropathic Pain | ||||||||||||||||||
Medical condition: Peripheral Neuropathic Pain | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) CZ (Completed) GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-002108-24 | Sponsor Protocol Number: SLC022/201 | Start Date*: 2009-03-10 | |||||||||||
Sponsor Name:Solace Pharmaceuticals Inc. | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study Evaluating the Efficacy and Tolerability of Oral SLC022 300 mg TID, a Glial Cell Modulating Agent, Versus Placebo in the Treatme... | |||||||||||||
Medical condition: Post herpetic neuralgia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-002208-24 | Sponsor Protocol Number: A3051103 | Start Date*: 2008-08-01 | |||||||||||
Sponsor Name:Pfizer Inc., 235 East 42nd Street,New York,NY 10017 | |||||||||||||
Full Title: A FOUR WEEK, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 2A STUDY OF VARENICLINE TARTRATE (CP-526,555) IN THE TREATMENT OF POST-HERPETIC NEURALGIA | |||||||||||||
Medical condition: POST-HERPETIC NEURALGIA | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-007478-39 | Sponsor Protocol Number: 42160443NPP2001 | Start Date*: 2009-10-07 | |||||||||||||||||||||
Sponsor Name:Janssen Cilag International, NV | |||||||||||||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42160443 in Subjects With Postherpetic Neuralgia and Post-T... | |||||||||||||||||||||||
Medical condition: Postherpetic Neuralgia and Post-Traumatic Neuralgia | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: BE (Completed) NL (Prematurely Ended) ES (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-002083-25 | Sponsor Protocol Number: LIDO2011 | Start Date*: 2011-12-05 | ||||||||||||||||
Sponsor Name:BG University Hospital Bergmannsheil GmbH | ||||||||||||||||||
Full Title: Is there a correlation between the pain relief and the A-delta- and C-fiber function after topical application of lidocaine (5%) in patients with peripheral neuropathic pain? | ||||||||||||||||||
Medical condition: Patients with proven diagnosis of painful peripheral neuropathic pain syndromes as diagnosed as: 1. Peripheral nerve lesion or 2. Postherpetic neuralgia. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002903-16 | Sponsor Protocol Number: 2197944/201 | Start Date*: 2013-04-08 | |||||||||||
Sponsor Name:Convergence Pharmaceuticals Ltd | |||||||||||||
Full Title: A randomised, double-blind, crossover study to compare the efficacy and safety of CNV2197944 75 mg tid versus placebo in patients with post-herpetic neuralgia | |||||||||||||
Medical condition: Post-herpetic Neuralgia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Completed) | |||||||||||||
Trial results: Removed from public view |
EudraCT Number: 2010-019101-42 | Sponsor Protocol Number: BIA-2093-308 | Start Date*: 2010-07-21 | |||||||||||
Sponsor Name:BIAL – PORTELA & Ca, S.A. | |||||||||||||
Full Title: A Phase 3, Double Blind, Randomized, Placebo Controlled, Parallel Group, Multicenter Clinical Study of Eslicarbazepine Acetate in Post-Herpetic Neuralgia | |||||||||||||
Medical condition: Post-herpetic neuralgia (PHN). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (Completed) AT (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-004232-31 | Sponsor Protocol Number: A6061025 | Start Date*: 2004-11-29 | |||||||||||
Sponsor Name:Pfizer Ltd | |||||||||||||
Full Title: A double-blind (third party open), placebo-controlled, parallel group, multiple dose study to investigate the safety, toleration and pharmacokinetics of [S,S]-Reboxetine in young and elderly health... | |||||||||||||
Medical condition: Postherpetic Neuralgia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-016766-86 | Sponsor Protocol Number: A0081224 | Start Date*: 2011-02-21 | |||||||||||
Sponsor Name:Pfizer Inc. | |||||||||||||
Full Title: A PHASE 3 DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, SAFETY AND EFFICACY STUDY OF ONCE DAILY CONTROLLED RELEASE PREGABALIN IN THE TREATMENT OF PATIENTS WITH POSTHERPETIC NEURALGIA (PROTOCOL A008... | |||||||||||||
Medical condition: postherpetic neuralgia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Prematurely Ended) SE (Completed) SK (Completed) BG (Completed) DE (Completed) HU (Completed) DK (Completed) PL (Completed) HR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-000280-16 | Sponsor Protocol Number: CEMA401A2201 | Start Date*: 2017-05-16 | |||||||||||
Sponsor Name:Novartis Pharma AG | |||||||||||||
Full Title: A double-blind, placebo-controlled, randomized dose ranging trial to determine the safety and efficacy of three dose levels of EMA401 in reducing 24-hour average pain intensity score in patients wi... | |||||||||||||
Medical condition: Post-herpetic neuralgia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (Prematurely Ended) SK (Prematurely Ended) AT (Prematurely Ended) NO (Prematurely Ended) DK (Prematurely Ended) ES (Prematurely Ended) CZ (Prematurely Ended) HU (Prematurely Ended) FR (Completed) BE (Prematurely Ended) PT (Prematurely Ended) PL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-000977-29 | Sponsor Protocol Number: EMA401-003 | Start Date*: 2011-07-12 | |||||||||||
Sponsor Name:Spinifex Pharmaceuticals Pty Ltd | |||||||||||||
Full Title: A double-blind, placebo-controlled, randomised trial to prove the therapeutic concept and to determine the safety, tolerability and pharmacokinetic profile of EMA401 (angiotensin II type 2 receptor... | |||||||||||||
Medical condition: postherpetic neuralgia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-005972-41 | Sponsor Protocol Number: A9001464 | Start Date*: 2012-08-22 | |||||||||||
Sponsor Name:Pfizer Inc. 235 East 42nd Street, New York, NY 10017 | |||||||||||||
Full Title: A PHASE 4 MULTICENTER, OPEN-LABEL, PILOT STUDY OF PREGABALIN AND PREDICTION OF TREATMENT RESPONSE IN PATIENTS WITH POSTHERPETIC NEURALGIA. | |||||||||||||
Medical condition: Postherpetic Neuralgia (PHN) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Prematurely Ended) ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-003197-57 | Sponsor Protocol Number: A0081181 | Start Date*: 2012-11-09 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Pfizer Worldwide Research and Development | ||||||||||||||||||||||||||||||||||||||
Full Title: A MULTIPLE DOSE PHARMACOKINETIC OPEN-LABEL STUDY OF PREGABALIN (LYRICA) IN HEALTHY LACTATING WOMEN | ||||||||||||||||||||||||||||||||||||||
Medical condition: neuropathic pain associated with diabetic peripheral neuropathy postherpetic neuralgia neuropathic pain related to spinal cord injury (US), fibromyalgia (US, JP) treatment of central and periphe... | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: BE (Completed) | ||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2004-000975-32 | Sponsor Protocol Number: RPCE03L1801 | Start Date*: 2004-11-09 |
Sponsor Name:UCB S.A. - Pharma Sector | ||
Full Title: An exploratory, double blind, randomized, placebo-controlled, prallel group, multicenter study, for the assessment of the efficacy, safety and tolerability of ucb34714 50mg oral capsules in b.i.d. ... | ||
Medical condition: post-herpetic neuralgia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) CZ (Completed) SK (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-000521-31 | Sponsor Protocol Number: PI12_01813 | Start Date*: 2013-12-26 | |||||||||||
Sponsor Name:Gerencia de Atención Primaria de Mallorca | |||||||||||||
Full Title: Efficacy and safety of gabapentin versus placebo to prevent the incidence of PostHerpetic Neuralgia | |||||||||||||
Medical condition: Postherpetic Neuralgia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.